For founders and owners of privately held medical product businesses, the amount of private investment dollars available is significant.
A U.S. launch of the product is expected in just a few weeks.
It is the pot of gold at the end of the medical rainbow—the promise that, by harnessing data, researchers can tailor drugs, devices, and treatments to the genetic configuration, lifestyle, and environment of individual patients.
Medtech decision makers must accurately predict future trends in order to chart the best future directions and identify the most advantageous areas for business investment.
Here’s a hint: EU MDR and recalls were among the hot topics.
Executive Vice President Geoff Martha will succeed Ishrak.
Software-powered PCBAs can help medical device engineers generate high-quality prototypes for complex electronics products in record speed.
The aging population and the rising rate of diabetes globally are fueling market growth.
The agency granted its first approval order under the humanitarian device exemption in spinal pediatrics in the last 15 years.
The revolution in data and technology should be pushing companies to focus on safeguarding intellectual property.